Source: https://law.justia.com/codes/maryland/2013/article-gcr/section-5-405/
Timestamp: 2018-12-17 11:54:01
Document Index: 311479427

Matched Legal Cases: ['§ 5', '§ 5', '§ 5', '§ 5', '§ 5', '§ 5', '§ 5']

§ 5-405 - Schedule IV :: 2013 Maryland Code :: US Codes and Statutes :: US Law :: Justia
Justia US Law US Codes and Statutes Maryland Code 2013 Maryland Code CRIMINAL LAW § 5-405 - Schedule IV
§ 5-405 - Schedule IV
MD Crim Law Code § 5-405 (2013) What's This?
(a) Schedule IV consists of each controlled dangerous substance:
(2) added to Schedule IV by the Department under § 5-202(b) of this title; or
(3) designated as a Schedule IV controlled dangerous substance by the federal government unless the Department objects under § 5-202(f) of this title.
(b) Substances listed in Schedule IV include a material, compound, mixture, or preparation that contains any quantity of the following substances having a potential for abuse associated with a depressant effect on the central nervous system:
(2) bromazepam;
(3) camazepam;
(4) chloral betaine;
(5) chloral hydrate;
(6) ethchlorvynol;
(16) ethinamate;
(17) ethylloflazepate;
(18) fludiazepam;
(19) flunitrazepam;
(20) flurazepam;
(21) halazepam;
(22) haloxazolam;
(23) ketazolam;
(24) loprazolam;
(25) lorazepam;
(26) lormetazepam;
(27) mebutamate;
(28) medazepam;
(29) methohexital;
(31) methylphenobarbital;
(32) nimetazepam;
(33) nitrozepam;
(34) nordiazepam;
(35) oxazepam;
(36) oxazolam;
(37) paraldehyde;
(38) petrichloral;
(42) temazepam;
(43) tetrazepam; and
(44) triazolam.
(c) Substances listed in Schedule IV include:
(1) a material, compound, mixture, or preparation that contains fenfluramine; and
(2) if its existence is possible:
(i) a salt of fenfluramine;
(ii) an optical, position, or geometric isomer of fenfluramine; and
(iii) a salt of an isomer of fenfluramine.
(d) Substances listed in Schedule IV include a material, compound, mixture, or preparation that contains any quantity of the following substances having a potential for abuse associated with a stimulant effect on the central nervous system:
(2) pemoline, including organometallic complexes and their chelates; and
(3) phentermine.
(e) By regulation, the Department may exempt from this section a compound, mixture, or preparation that contains a depressant substance listed in subsection (b) of this section if:
(1) the compound, mixture, or preparation contains an active medicinal ingredient that does not have a depressant effect on the central nervous system; and
(2) the admixtures are included in combinations, quantity, proportion, or concentration that vitiate the potential for abuse of the substances that have a depressant effect on the central nervous system.
(f) The Department may not add a substance to Schedule IV under § 5-202 of this title unless the Department finds that:
(1) the substance has a low potential for abuse relative to the substances listed in Schedule III;